Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials

about

Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Item

http://www.wikidata.org/entity/Q57300671

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Efficacy of l-Ornithine l-Aspa ...... f Randomized Controlled Trials

@en

Efficacy of l-Ornithine l-Aspa ...... f Randomized Controlled Trials

@nl

type

Item

label

Efficacy of l-Ornithine l-Aspa ...... f Randomized Controlled Trials

@en

Efficacy of l-Ornithine l-Aspa ...... f Randomized Controlled Trials

@nl

prefLabel

Efficacy of l-Ornithine l-Aspa ...... f Randomized Controlled Trials

@en

Efficacy of l-Ornithine l-Aspa ...... f Randomized Controlled Trials

@nl

P1476

Efficacy of l-Ornithine l-Aspa ...... f Randomized Controlled Trials

@en

P2093

Gerald Kircheis

http://www.w3.org/2001/XMLSchema#string

Mark J W McPhail

http://www.w3.org/2001/XMLSchema#string

Norbert Hilger

http://www.w3.org/2001/XMLSchema#string

Roger F Butterworth

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Management of overt hepatic encephalopathy

Quantifying heterogeneity in a meta-analysis

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes

Neuropsychological characterization of hepatic encephalopathy

Rifaximin treatment in hepatic encephalopathy

Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial

Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.

Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial.

P304

301-313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCEH.2018.05.004

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30302048

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

P932

6175748

http://www.w3.org/2001/XMLSchema#string